Osteogenic regulation of vascular calcification: an early perspective
The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Abstract
Cardiovascular calcification is a common consequence of aging, diabetes, hypercholesterolemia, mechanically abnormal valve function, and chronic renal insufficiency. Although vascular calcification may appear to be a uniform response to vascular insult, it is a heterogenous disorder, with overlapping yet distinct mechanisms of initiation and progression. A minimum of four histoanatomic variants—atherosclerotic (fibrotic) calcification, cardiac valve calcification, medial artery calcification, and vascular calciphylaxis—arise in response to metabolic, mechanical, infectious, and inflammatory injuries. Common to the first three variants is a variable degree of vascular infiltration by T cells and macrophages. Once thought benign, the deleterious clinical consequences of calcific vasculopathy are now becoming clear; stroke, amputation, ischemic heart disease, and increased mortality are portended by the anatomy and extent of calcific vasculopathy. Along with dystrophic calcium deposition in dying cells and lipoprotein deposits, active endochondral and intramembranous (nonendochondral) ossification processes contribute to vascular calcium load. Thus vascular calcification is subject to regulation by osteotropic hormones and skeletal morphogens in addition to key inhibitors of passive tissue mineralization. In response to oxidized lipids, inflammation, and mechanical injury, the microvascular smooth muscle cell becomes activated. Orthotopically, proliferating stromal myofibroblasts provide osteoprogenitors for skeletal growth and fracture repair; however, in valves and arteries, vascular myofibroblasts contribute to cardiovascular ossification. Current data suggest that paracrine signals are provided by bone morphogenetic protein-2, Wnts, parathyroid hormone-related polypeptide, osteopontin, osteoprotegerin, and matrix Gla protein, all entrained to endocrine, metabolic, inflammatory, and mechanical cues. In end-stage renal disease, a “perfect storm” of vascular calcification often occurs, with hyperglycemia, hyperphosphatemia, hypercholesterolemia, hypertension, parathyroid hormone resistance, and iatrogenic calcitriol excess contributing to severe calcific vasculopathy. This brief review recounts emerging themes in the pathobiology of vascular calcification and highlights some fundamental deficiencies in our understanding of vascular endocrinology and metabolism that are immediately relevant to human health and health care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“Thus, given our aging and “dysmetabolic” population (13, 41, 53, 122), a better understanding of vascular calcification is now sorely needed for improving human health and health care.”
BackgroundNakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608 · cited 1×
“This occurs because Msx2 upregulates osterix, or Osx, a global transcriptional regulator of mineralization and osteoblast differentiation (64), via a Runx2-independent signaling mechanism (Ref.”
BackgroundOsteoblastic cells regulate the haematopoietic stem cell niche
Calvi, L. M., Adams, G. B., Weibrecht, K. W., Weber, J. M., Olson, D. P., Knight, M. C., Martin, R. P., Schipani, E., Divieti, P., Bringhurst, F. R., et al. (2003) · Nature · doi:10.1038/nature02040 · Cited by 3,455
Identification of the haematopoietic stem cell niche and control of the niche size
Zhang, J., Niu, C., Ye, L., Huang, H., He, X., Tong, W.-G., Ross, J., Haug, J., Johnson, T., Feng, J. Q., et al. (2003) · Nature · doi:10.1038/nature02041 · Cited by 2,959
Goodman, W. G., Goldin, J., Kuizon, B. D., Yoon, C., Gales, B., Sider, D., Wang, Y., Chung, J., Emerick, A., Greaser, L., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422003 · Cited by 2,509
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Oodman, W. I. G. G., Oldin, J. O. G., Uizon, D. K., Oon, C. H. Y., Ales, B. A. G., Ider, D. O. S., Ang, W. C., Oanie, J., Hung, C., Merick, A. L. E., et al. (2000) · Cited by 2,191
Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
Luo, G., Ducy, P., McKee, M. D., Pinero, G. J., Loyer, E., Behringer, R. R., & Karsenty, G. (1997) · Nature · doi:10.1038/386078a0 · Cited by 2,120
Estrogen plus Progestin and the Risk of Coronary Heart Disease
Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065 · cited 1×
“However, as recently learned from the Women’s Health Initiative, a progestin-estrogen hormone replacement combination does not prevent cardiovascular mortality (56) and stroke (114) and, in fact, increases risk.”
BackgroundClinical Factors Associated With Calcific Aortic Valve Disease
Stewart, B. F., Siscovick, D., Lind, B. K., Gardin, J. M., Gottdiener, J. S., Smith, V. E., Kitzman, D. W., & Otto, C. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00563-3 · Cited by 2,029 · cited 2×
“Thus, as recently considered (32, 70, 100, 116), valve calcification of the aged is likely initiated via mechanisms overlapping yet distinct from atherosclerotic calcification.”
Background
Cited by
Vascular Calcification: Pathobiological Mechanisms and Clinical Implications
Johnson, R. C., Leopold, J. A., & Loscalzo, J. (2006) · Circulation Research · doi:10.1161/01.res.0000249379.55535.21 · Cited by 944
Arterial Stiffness and Cardiovascular Risk in Hypertension
Boutouyrie, P., Chowienczyk, P., Humphrey, J. D., & Mitchell, G. F. (2021) · Circulation Research · doi:10.1161/circresaha.121.318061 · Cited by 748
Calcification of Tissue Heart Valve Substitutes: Progress Toward Understanding and Prevention
Schoen, F. J., & Levy, R. J. (2005) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2004.06.033 · Cited by 725
Calcium/Vitamin D Supplementation and Cardiovascular Events
Hsia, J., Heiss, G., Ren, H., Allison, M., Dolan, N. C., Greenland, P., Heckbert, S. R., Johnson, K. C., Manson, J. E., Sidney, S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.673491 · Cited by 662
Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin
Collin-Osdoby, P. (2004) · Circulation Research · doi:10.1161/01.res.0000149165.99974.12 · Cited by 473
Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals
Shao, J.-S., Cheng, S.-L., Pingsterhaus, J. M., Charlton-Kachigian, N., Loewy, A. P., & Towler, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524140 · Cited by 452
Self-citationBioprinted Osteogenic and Vasculogenic Patterns for Engineering 3D Bone Tissue
Byambaa, B., Annabi, N., Yue, K., Trujillo‐de Santiago, G., Alvarez, M. M., Jia, W., Kazemzadeh‐Narbat, M., Shin, S. R., Tamayol, A., & Khademhosseini, A. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700015 · Cited by 394
Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease
Sabit, R., Bolton, C. E., Edwards, P. H., Pettit, R. J., Evans, W. D., McEniery, C. M., Wilkinson, I. B., Cockcroft, J. R., & Shale, D. J. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-067oc · Cited by 374
Nadra, I., Mason, J. C., Philippidis, P., Florey, O., Smythe, C. D. W., McCarthy, G. M., Landis, R. C., & Haskard, D. O. (2005) · Circulation Research · doi:10.1161/01.res.0000171451.88616.c2 · Cited by 360
Bone Morphogenetic Proteins in Vascular Calcification
Hruska, K. A., Mathew, S., & Saab, G. (2005) · Circulation Research · doi:10.1161/01.res.00000175571.53833.6c · Cited by 360
Molecular Mechanisms of Vascular Calcification: Lessons Learned From The Aorta
Shao, J.-S., Cai, J., & Towler, D. A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000220441.42041.20 · Cited by 348
Self-citationCalcific Aortic Valve Stenosis: Methods, Models, and Mechanisms
Miller, J. D., Weiss, R. M., & Heistad, D. D. (2011) · Circulation Research · doi:10.1161/circresaha.110.234138 · Cited by 323
Bennett, B. J., Scatena, M., Kirk, E. A., Rattazzi, M., Varon, R. M., Averill, M., Schwartz, S. M., Giachelli, C. M., & Rosenfeld, M. E. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000236428.91125.e6 · Cited by 304
Chai, Y. C., Carlier, A., Bolander, J., Roberts, S. J., Geris, L., Schrooten, J., Van Oosterwyck, H., & Luyten, F. P. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.07.002 · Cited by 305
Simmons, C. A., Grant, G. R., Manduchi, E., & Davies, P. F. (2005) · Circulation Research · doi:10.1161/01.res.0000161998.92009.64 · Cited by 274
Unanswered Questions — Drug-Eluting Stents and the Risk of Late Thrombosis
Maisel, W. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068305 · Cited by 268
Angiogenesis and Pericytes in the Initiation of Ectopic Calcification
Collett, G. D. M., & Canfield, A. E. (2005) · Circulation Research · doi:10.1161/01.res.0000163634.51301.0d · Cited by 260
Tanikawa, T., Okada, Y., Tanikawa, R., & Tanaka, Y. (2009) · Journal of Vascular Research · doi:10.1159/000226225 · Cited by 191
“Vascular calcification is a pathological process that occurs in many diseases, including atherosclerosis, diabetes and uremia [”
BackgroundRole of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders
Workgroup, O. B. O. T. E. R. O. (., Carrillo-López, N., Martínez-Arias, L., Fernández-Villabrille, S., Ruiz-Torres, M. P., Dusso, A., Cannata-Andía, J. B., Naves-Díaz, M., & Panizo, S. (2021) · Calcified Tissue International · doi:10.1007/s00223-020-00803-2 · Cited by 91
Metadata
- Authors
- Vattikuti, R., & Towler, D. A.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2004-05
- Volume
- 286
- Issue
- 5
- Pages
- E686-E696
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2154833555
- Cited by
- 397
- References
- 117
- FWCI
- 18.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.